On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin
about
Serglycin is the major secreted proteoglycan in macrophages and has a role in the regulation of macrophage tumor necrosis factor-alpha secretion in response to lipopolysaccharideHeparin improves organ microcirculatory disturbances in caerulein-induced acute pancreatitis in rats.Soluble cytokine receptors: basic immunology and clinical applications.Age-dependent levels of select immunological mediators in sera of healthy childrenReview article: potential therapeutic applications and mechanisms of action of heparin in inflammatory bowel disease.Early intravenous unfractionated heparin and outcome in acute lung injury and acute respiratory distress syndrome: a retrospective propensity matched cohort study.Heparin reduced mortality and sepsis in severely burned childrenSecretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease.Tumor necrosis factor (TNF)-dependent shedding of the p55 TNF receptor in a baboon model of bacteremia.Cytokines in recurrent miscarriage.Inhibitory effect of heparin-derived oligosaccharides on secretion of interleukin-4 and interleukin-5 from human peripheral blood T lymphocytes.Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier functionCD4+ beta islet cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice.Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8.Extracellular angiogenic growth factor interactions: an angiogenesis interactome survey.Management of severe burn injuries with topical heparin: the first evidence-based study in Ghana.Syndecan-1 is an in vivo suppressor of Gram-positive toxic shockMolecular functions of syndecan-1 in disease.Microbial heparin/heparan sulphate lyases: potential and applications.Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use.Tumor necrosis factor-dependent adhesions as a major protective mechanism early in septic peritonitis in mice.Heparan sulfate plays a central role in a dynamic in vitro model of protein-losing enteropathy.Heparan sulfate depletion amplifies TNF-alpha-induced protein leakage in an in vitro model of protein-losing enteropathy.Endothelial cells and extracellular calmodulin inhibit monocyte tumor necrosis factor release and augment neutrophil elastase release.The efficacy of recombinant human activated protein C (rhAPC) vs antithrombin III (at III) vs heparin, in the healing process of partial-thickness burns: a comparative study.Transport and binding of tumor necrosis factor-α in articular cartilage depend on its quaternary structure.Nutrition support affects the distribution and organ uptake of cachectin/tumor necrosis factor in rats.Serum levels of interleukin-6 are not dependent on the kidney function.Heparin attenuates TNF-alpha induced inflammatory response through a CD11b dependent mechanism.Heparin and low-molecular-weight heparin (enoxaparin) significantly ameliorate experimental colitis in rats.Efficacy of low molecular weight heparin in patients with acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support.Nadroparine blunts lipopolysaccharide-induced hypothermia and behavioral depression in mice.Molecular-weight-dependent effects of nonanticoagulant heparins on allergic airway responses.Proteoglycans as Immunomodulators of the Innate Immune Response to Lung Infection.Linear basic peptides for targeting interferon-gamma-glycosaminoglycan interactions: synthesis and inhibitory properties.Inhibition of allergic late airway responses by inhaled heparin-derived oligosaccharides.
P2860
Q28513593-3AD897FD-2A10-4AE1-BE08-17E2ED068239Q33205619-AF6D3DBD-F497-43A0-98A2-074109968900Q33688222-0FA14108-DCCD-471F-8A01-B3A41A3D1A33Q33992976-6985A8EA-2483-4C80-BE7A-351E98092D1EQ34078523-BAD01BD9-0B14-4F11-AD7E-AB14C14E394AQ34380703-E65B7470-4763-4CF1-AB36-543D32348C2EQ35279561-B3BC6FFF-9427-4EE6-95F1-5A349BF19E61Q35351969-9E5A1FAD-F38A-43E1-9D4E-F1CE05B863F3Q35381050-48E2B375-3A10-46BF-8CF6-A7B90B54ECC8Q35918347-A4BD4605-32AA-40F2-B2CF-8867A716FB01Q36076384-3F94D01B-C4C6-4B83-87C5-24AD0FB40215Q36227233-C934F859-5B14-44E3-94E1-D14DE11D3603Q36365153-88B37CD6-E829-4D80-B3EC-AAEF325C689FQ36453167-99D986D3-FB0B-45DC-B3ED-EF6EA84952FCQ36489766-DD9E36C9-D32E-43F8-BD16-AB3AB57DDBAFQ36576521-E9F7B630-2EFC-4A95-8FEA-0334A97DE071Q36761832-A1F96581-211D-4DCD-B157-50DA400251A5Q37950202-927DE26C-9429-424F-8020-B5DF8428C190Q37990767-DE2AA62B-E88A-4E83-8451-D0526AC10E4DQ38418286-B15F0859-CC31-493C-8643-7EF1B37BA89AQ39520282-F16CFB3D-D7EF-4332-9B37-43E736E59386Q40325540-F74F5A78-6A9A-437A-93CD-E8B8275A01D2Q40480014-55FFE969-7DFB-4E78-B8A6-E24A478210E1Q41111030-05645D78-0F63-4163-AAD6-7C55D48D5788Q41887896-102E341D-4A93-4858-BC74-118DA211A2E9Q41887934-786BD831-9FC0-465F-A9D5-61FEB9406949Q42626877-62D8DF4D-798B-43C6-80BE-600841537D08Q42706130-0B4D477B-2908-47B2-8BF8-2E0CEFC62230Q43086370-D47F2CA6-E398-41AD-9E37-260D79AD3E7BQ43742733-3DBBBD5D-DAD0-4A80-9D81-7F051F98F2C0Q45156975-70473757-CAD5-46E8-8458-D1E24C8A59F2Q46153050-BD73CD77-9410-45AC-BA79-64DAF2A412C2Q47271943-F65D1DC1-874D-483C-9428-77E5A192DBB5Q47719302-94E20632-381C-420E-9F9F-E25F7167CDFCQ47979670-77C78376-0DC9-4E6B-931C-FCF5008EA37BQ53986493-661E3F7C-4D98-4E4F-82D4-CDF7EB60EF32
P2860
On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
On the binding of tumor necros ...... F-binding protein I by heparin
@en
type
label
On the binding of tumor necros ...... F-binding protein I by heparin
@en
prefLabel
On the binding of tumor necros ...... F-binding protein I by heparin
@en
P2093
P2860
P356
P1476
On the binding of tumor necros ...... F-binding protein I by heparin
@en
P2093
P2860
P304
P356
10.1172/JCI115530
P407
P577
1991-12-01T00:00:00Z